23 10, 2018

Epilepsy Society, UCL and Congenica Join Forces in Genomic Study to Identify Causes of Unexpected Deaths in Epilepsy

October 23rd, 2018|Tags: , , |

Congenica, the global diagnostic decision support platform provider, today announced a key partnership with the UK’s Epilepsy Society to study the genomics of sudden unexpected death in epilepsy (SUDEP). The new collaboration aims to […]

17 10, 2018

Congenica earns major role in supporting world’s first routine national genomic medicine service

October 17th, 2018|Tags: , , , |

  • Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service

Cambridge, United Kingdom – 17 October, 2018 – Congenica has been awarded a multi-year […]

12 02, 2018

Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

February 12th, 2018|Tags: , , |

Cambridge, United Kingdom and Dublin, Ireland – 12 February 2018 – New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics […]

6 09, 2017

Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project

September 6th, 2017|Tags: , , |

Cambridge, UK, September 06, 2017 Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part […]

18 01, 2017

Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits

January 18th, 2017|Tags: , , , |

“Rare Disease Diagnosis – Shortening Odysseys, Improving Outcomes,” presentation by Congenica at PMWC 2017, January 23

Whole genome analysis (WGA) enables rapid diagnosis of rare disease, ensuring that an appropriate course of management and treatment can […]